vs
美商海盗船（CRSR）与Revvity（RVTY）财务数据对比。点击上方公司名可切换其他公司
Revvity的季度营收约是美商海盗船的1.8倍（$772.1M vs $436.9M），Revvity净利率更高（12.7% vs 5.9%，领先6.8%），Revvity同比增速更快（5.9% vs 5.6%），Revvity自由现金流更多（$161.8M vs $32.9M），过去两年美商海盗船的营收复合增速更高（13.8% vs 9.0%）
美商海盗船是源自美国的电脑外设与电竞硬件品牌，总部位于加利福尼亚州米尔皮塔斯。公司创立于1994年，原名海盗船微系统，后更名为海盗船组件、海盗船内存，2007年重新在特拉华州注册。主打产品涵盖高速内存模块、电源、闪存、CPU显卡与机箱散热、电竞外设、电脑机箱等各类电脑相关产品。
Revvity是一家美国生命科学与诊断领域企业，主要服务制药、生物技术行业客户，重点围绕细胞治疗、基因治疗等前沿技术领域提供相关产品与解决方案，其前身为业务布局多元的老牌企业珀金埃尔默。
CRSR vs RVTY — 直观对比
营收规模更大
RVTY
是对方的1.8倍
$436.9M
营收增速更快
RVTY
高出0.2%
5.6%
净利率更高
RVTY
高出6.8%
5.9%
自由现金流更多
RVTY
多$128.9M
$32.9M
两年增速更快
CRSR
近两年复合增速
9.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $436.9M | $772.1M |
| 净利润 | $25.8M | $98.4M |
| 毛利率 | 33.1% | — |
| 营业利润率 | 6.2% | 14.5% |
| 净利率 | 5.9% | 12.7% |
| 营收同比 | 5.6% | 5.9% |
| 净利润同比 | 1028.2% | 3.9% |
| 每股收益（稀释后） | $0.23 | $0.86 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CRSRRVTY
| Q4 25 | $436.9M | $772.1M | ||
| Q3 25 | $345.8M | $698.9M | ||
| Q2 25 | $320.1M | $720.3M | ||
| Q1 25 | $369.8M | $664.8M | ||
| Q4 24 | $413.6M | $729.4M | ||
| Q3 24 | $304.2M | $684.0M | ||
| Q2 24 | $261.3M | $691.7M | ||
| Q1 24 | $337.3M | $649.9M |
净利润CRSRRVTY
| Q4 25 | $25.8M | $98.4M | ||
| Q3 25 | $-10.6M | $46.7M | ||
| Q2 25 | $-20.9M | $53.9M | ||
| Q1 25 | $-10.5M | $42.2M | ||
| Q4 24 | $2.3M | $94.6M | ||
| Q3 24 | $-51.7M | $94.4M | ||
| Q2 24 | $-24.2M | $55.4M | ||
| Q1 24 | $-11.6M | $26.0M |
毛利率CRSRRVTY
| Q4 25 | 33.1% | — | ||
| Q3 25 | 26.9% | 53.6% | ||
| Q2 25 | 26.8% | 54.5% | ||
| Q1 25 | 27.7% | 56.5% | ||
| Q4 24 | 26.2% | — | ||
| Q3 24 | 22.9% | 56.3% | ||
| Q2 24 | 24.1% | 55.7% | ||
| Q1 24 | 25.7% | 54.6% |
营业利润率CRSRRVTY
| Q4 25 | 6.2% | 14.5% | ||
| Q3 25 | -1.6% | 11.7% | ||
| Q2 25 | -5.3% | 12.6% | ||
| Q1 25 | -0.6% | 10.9% | ||
| Q4 24 | 1.4% | 16.3% | ||
| Q3 24 | -6.9% | 14.3% | ||
| Q2 24 | -9.5% | 12.4% | ||
| Q1 24 | -3.0% | 6.8% |
净利率CRSRRVTY
| Q4 25 | 5.9% | 12.7% | ||
| Q3 25 | -3.1% | 6.7% | ||
| Q2 25 | -6.5% | 7.5% | ||
| Q1 25 | -2.8% | 6.4% | ||
| Q4 24 | 0.6% | 13.0% | ||
| Q3 24 | -17.0% | 13.8% | ||
| Q2 24 | -9.3% | 8.0% | ||
| Q1 24 | -3.4% | 4.0% |
每股收益（稀释后）CRSRRVTY
| Q4 25 | $0.23 | $0.86 | ||
| Q3 25 | $-0.09 | $0.40 | ||
| Q2 25 | $-0.16 | $0.46 | ||
| Q1 25 | $-0.10 | $0.35 | ||
| Q4 24 | $0.01 | $0.77 | ||
| Q3 24 | $-0.56 | $0.77 | ||
| Q2 24 | $-0.28 | $0.45 | ||
| Q1 24 | $-0.12 | $0.21 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $919.9M |
| 总债务越低越好 | $121.3M | — |
| 股东权益账面价值 | $633.6M | $7.3B |
| 总资产 | $1.3B | $12.2B |
| 负债/权益比越低杠杆越低 | 0.19× | — |
8季度趋势，按日历期对齐
现金及短期投资CRSRRVTY
| Q4 25 | — | $919.9M | ||
| Q3 25 | — | $931.4M | ||
| Q2 25 | — | $991.8M | ||
| Q1 25 | — | $1.1B | ||
| Q4 24 | — | $1.2B | ||
| Q3 24 | — | $1.2B | ||
| Q2 24 | — | $2.0B | ||
| Q1 24 | — | $1.7B |
总债务CRSRRVTY
| Q4 25 | $121.3M | — | ||
| Q3 25 | $122.9M | — | ||
| Q2 25 | $124.4M | — | ||
| Q1 25 | $148.7M | — | ||
| Q4 24 | $173.5M | — | ||
| Q3 24 | $177.2M | — | ||
| Q2 24 | $180.3M | — | ||
| Q1 24 | $183.3M | — |
股东权益CRSRRVTY
| Q4 25 | $633.6M | $7.3B | ||
| Q3 25 | $600.2M | $7.4B | ||
| Q2 25 | $603.9M | $7.6B | ||
| Q1 25 | $608.8M | $7.6B | ||
| Q4 24 | $604.3M | $7.7B | ||
| Q3 24 | $598.5M | $7.9B | ||
| Q2 24 | $642.7M | $7.9B | ||
| Q1 24 | $663.5M | $7.8B |
总资产CRSRRVTY
| Q4 25 | $1.3B | $12.2B | ||
| Q3 25 | $1.2B | $12.1B | ||
| Q2 25 | $1.2B | $12.4B | ||
| Q1 25 | $1.2B | $12.4B | ||
| Q4 24 | $1.2B | $12.4B | ||
| Q3 24 | $1.2B | $12.8B | ||
| Q2 24 | $1.2B | $13.4B | ||
| Q1 24 | $1.3B | $13.4B |
负债/权益比CRSRRVTY
| Q4 25 | 0.19× | — | ||
| Q3 25 | 0.20× | — | ||
| Q2 25 | 0.21× | — | ||
| Q1 25 | 0.24× | — | ||
| Q4 24 | 0.29× | — | ||
| Q3 24 | 0.30× | — | ||
| Q2 24 | 0.28× | — | ||
| Q1 24 | 0.28× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $38.2M | $182.0M |
| 自由现金流经营现金流 - 资本支出 | $32.9M | $161.8M |
| 自由现金流率自由现金流/营收 | 7.5% | 21.0% |
| 资本支出强度资本支出/营收 | 1.2% | 2.6% |
| 现金转化率经营现金流/净利润 | 1.48× | 1.85× |
| 过去12个月自由现金流最近4个季度 | $34.7M | $509.4M |
8季度趋势，按日历期对齐
经营现金流CRSRRVTY
| Q4 25 | $38.2M | $182.0M | ||
| Q3 25 | $-37.0M | $138.5M | ||
| Q2 25 | $30.2M | $134.3M | ||
| Q1 25 | $18.8M | $128.2M | ||
| Q4 24 | $55.6M | $174.2M | ||
| Q3 24 | $25.1M | $147.9M | ||
| Q2 24 | $-18.5M | $158.6M | ||
| Q1 24 | $-26.3M | $147.6M |
自由现金流CRSRRVTY
| Q4 25 | $32.9M | $161.8M | ||
| Q3 25 | $-41.3M | $120.0M | ||
| Q2 25 | $27.5M | $115.5M | ||
| Q1 25 | $15.7M | $112.2M | ||
| Q4 24 | $54.1M | $149.8M | ||
| Q3 24 | $21.8M | $125.6M | ||
| Q2 24 | $-21.0M | $136.6M | ||
| Q1 24 | $-28.8M | $129.7M |
自由现金流率CRSRRVTY
| Q4 25 | 7.5% | 21.0% | ||
| Q3 25 | -12.0% | 17.2% | ||
| Q2 25 | 8.6% | 16.0% | ||
| Q1 25 | 4.2% | 16.9% | ||
| Q4 24 | 13.1% | 20.5% | ||
| Q3 24 | 7.2% | 18.4% | ||
| Q2 24 | -8.0% | 19.7% | ||
| Q1 24 | -8.6% | 20.0% |
资本支出强度CRSRRVTY
| Q4 25 | 1.2% | 2.6% | ||
| Q3 25 | 1.3% | 2.6% | ||
| Q2 25 | 0.8% | 2.6% | ||
| Q1 25 | 0.8% | 2.4% | ||
| Q4 24 | 0.4% | 3.4% | ||
| Q3 24 | 1.1% | 3.3% | ||
| Q2 24 | 1.0% | 3.2% | ||
| Q1 24 | 0.7% | 2.7% |
现金转化率CRSRRVTY
| Q4 25 | 1.48× | 1.85× | ||
| Q3 25 | — | 2.97× | ||
| Q2 25 | — | 2.49× | ||
| Q1 25 | — | 3.03× | ||
| Q4 24 | 24.30× | 1.84× | ||
| Q3 24 | — | 1.57× | ||
| Q2 24 | — | 2.87× | ||
| Q1 24 | — | 5.67× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CRSR
| Gamer And Creator Peripherals | $164.9M | 38% |
| Memory Products | $156.1M | 36% |
| Inventory Costs | $85.6M | 20% |
| Other Segment Items | $16.9M | 4% |
| Other | $13.3M | 3% |
RVTY
| Immunodiagnostics | $240.8M | 31% |
| Life Sciences | $191.4M | 25% |
| Reproductive Health | $149.3M | 19% |
| Segment Operating Income | $132.0M | 17% |
| Software | $62.3M | 8% |
